COBICISTAT Pharmacologic Class Indexing
- Class set ID
- 59e43a79-4e97-4edc-853b-3b4dd157d06a
- Version
- 3
- Effective date
- 20220805
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
Label, Manufacturer, Effective table| Label | Manufacturer | Effective | SPL version |
|---|
| These highlights do not include all the information needed to use SYMTUZA safely and effectively. See full prescribing information for SYMTUZA. SYMTUZA ® (darunavir, cobicistat, emtricitabine, and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2018 | Janssen Products LP | AMPAC Fine Chemicals | Gilead Alberta ULC | Patheon, Inc. | Evonik Operations GmbH | Janssen Pharmaceutica NV | Union Quimico Farmaceutica SA (Uquifa) | Janssen Cilag SpA | Esteve Quimica, SA | Yuhan Chemical, Inc. | Janssen Ortho LLC | Janssen Pharmaceuticals, Inc. | Janssen Pharmaceutical Sciences Unlimited Company | Porton Pharma Solutions Ltd | Thermo Fisher Scientific Cork Limited | 20260417 | 23 |
| These highlights do not include all the information needed to use TYBOST safely and effectively. See full prescribing information for TYBOST. TYBOST ® (cobicistat) tablets, for oral use Initial U.S. Approval: 2012 | Gilead Sciences, Inc. | 20260210 | 16 |
| These highlights do not include all the information needed to use PREZCOBIX safely and effectively. See full prescribing information for PREZCOBIX. PREZCOBIX ® (darunavir and cobicistat) tablets, for oral use PREZCOBIX ® PED (darunavir and cobicistat) tablets for oral suspension Initial U.S. Approval: 2015 | Janssen Products, LP | Gilead Alberta ULC | Cilag AG | Porton Pharma Solutions Ltd | Janssen Ortho LLC | Janssen Pharmaceutical Sciences Unlimited Company | Thermo Fisher Scientific Cork Limited | Yuhan Chemical, Inc. | Patheon Inc. | 20260201 | 28 |
| These highlights do not include all the information needed to use EVOTAZ safely and effectively. See full prescribing information for EVOTAZ. EVOTAZ ® (atazanavir and cobicistat) tablet, for oral use Initial U.S. Approval: 2015 | E.R. Squibb & Sons, L.L.C. | 20250512 | 16 |
| These highlights do not include all the information needed to use STRIBILD safely and effectively. See full prescribing information for STRIBILD. STRIBILD ® (elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2012 | Gilead Sciences, Inc. | 20250204 | 22 |
| These highlights do not include all the information needed to use GENVOYA safely and effectively. See full prescribing information for GENVOYA. GENVOYA ® (elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2015 | Gilead Sciences, Inc. | 20250203 | 22 |
| These highlights do not include all the information needed to use PREZCOBIX safely and effectively. See full prescribing information for PREZCOBIX. PREZCOBIX ® (darunavir and cobicistat) tablets, for oral use Initial U.S. Approval: 2015 | A-S Medication Solutions | 20240102 | 9 |
| These highlights do not include all the information needed to use STRIBILD safely and effectively. See full prescribing information for STRIBILD. STRIBILD ® (elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2012 | Avera McKennan Hospital | 20170320 | 1 |
| These highlights do not include all the information needed to use STRIBILD safely and effectively. See full prescribing information for STRIBILD. STRIBILD ® (elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2012 | State of Florida DOH Central Pharmacy | 20140306 | 1 |